Hicet-AX Tablet SR is a sustained-release formulation combining Cetirizine 10mg and Ambroxol 75mg, designed for the effective management of allergic respiratory conditions accompanied by mucus hypersecretion. Cetirizine, a second-generation antihistamine, selectively inhibits peripheral H1 receptors, thereby alleviating symptoms such as sneezing, rhinorrhea, nasal congestion, and pruritus associated with allergic rhinitis and chronic urticaria, without causing significant sedation. Ambroxol, a mucolytic agent, enhances the clearance of mucus by stimulating surfactant production and promoting ciliary motility, facilitating expectoration in conditions like bronchitis and other respiratory tract infections characterized by viscous mucus. The sustained-release matrix ensures a prolonged therapeutic effect, improving patient compliance by reducing dosing frequency. Hicet-AX Tablet SR is indicated for patients requiring simultaneous relief from allergic symptoms and effective mucus clearance. It should be used with caution in patients with hepatic or renal impairment, and contraindicated in individuals with known hypersensitivity to either component. Common adverse effects may include mild gastrointestinal disturbances and headache. As with all medications, it is recommended to use Hicet-AX under medical supervision to ensure appropriate dosing and monitoring for potential drug interactions.